Hamilton Capital Partners LLC increased its position in shares of Oracle Corporation (NYSE:ORCL – Free Report) by 27.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 97,408 shares of the enterprise software provider’s stock after buying an additional 21,025 shares during the quarter. Oracle comprises about 4.5% of Hamilton Capital Partners LLC’s portfolio, making the stock its 10th biggest position. Hamilton Capital Partners LLC’s holdings in Oracle were worth $14,330,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. FSA Wealth Management LLC acquired a new position in shares of Oracle during the third quarter worth approximately $28,000. Mpwm Advisory Solutions LLC grew its position in Oracle by 76.9% in the 3rd quarter. Mpwm Advisory Solutions LLC now owns 115 shares of the enterprise software provider’s stock valued at $32,000 after purchasing an additional 50 shares during the period. Turning Point Benefit Group Inc. bought a new stake in Oracle during the 3rd quarter valued at $35,000. HFM Investment Advisors LLC increased its stake in Oracle by 290.9% during the 4th quarter. HFM Investment Advisors LLC now owns 129 shares of the enterprise software provider’s stock valued at $25,000 after purchasing an additional 96 shares in the last quarter. Finally, Basepoint Wealth LLC acquired a new position in Oracle during the fourth quarter worth $26,000. Institutional investors own 42.44% of the company’s stock.
Oracle Stock Performance
Shares of ORCL stock opened at $165.00 on Wednesday. The company has a debt-to-equity ratio of 2.84, a current ratio of 1.12 and a quick ratio of 1.35. The firm has a 50-day moving average of $190.13 and a 200-day moving average of $176.74. Oracle Corporation has a one year low of $134.57 and a one year high of $345.72. The company has a market cap of $474.55 billion, a P/E ratio of 28.30, a P/E/G ratio of 1.10 and a beta of 1.65.
Oracle Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 24th. Stockholders of record on Friday, July 10th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, July 10th. This represents a $2.00 annualized dividend and a dividend yield of 1.2%. Oracle’s dividend payout ratio is currently 34.31%.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on ORCL shares. Evercore reaffirmed an “outperform” rating and issued a $245.00 price objective on shares of Oracle in a research note on Monday, June 8th. Guggenheim reissued a “buy” rating and set a $400.00 target price on shares of Oracle in a research report on Thursday, June 11th. TD Cowen raised their price target on shares of Oracle from $250.00 to $300.00 and gave the company a “buy” rating in a research report on Monday, June 8th. UBS Group lifted their price target on Oracle from $250.00 to $285.00 and gave the company a “buy” rating in a research note on Tuesday, June 2nd. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on Oracle from $375.00 to $300.00 and set a “buy” rating for the company in a report on Monday, March 9th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $268.27.
Read Our Latest Report on ORCL
Oracle News Roundup
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Several recent articles argue the sell-off may be overdone, pointing to Oracle’s massive AI backlog, strong cloud demand, and the potential for backlog conversion to drive revenue and earnings over the next several years. Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Positive Sentiment: Oracle’s healthcare AI expansion and Baystate Health partnership suggest continued adoption of Oracle Health products, which could support future cloud and software growth. Baystate Health and Oracle Health Expand Strategic Collaboration to Create a Connected and Patient-Centered Care Experience
- Neutral Sentiment: Analysts and commentators remain divided, with some calling Oracle a buying opportunity while others say the stock is still digesting heavy AI spending, debt, and restructuring costs. Oracle workforce shrinks by about 13%
- Negative Sentiment: The job cuts and related $1.84 billion restructuring charge reinforce concerns that Oracle’s AI push is pressuring near-term profitability and cash flow, even as long-term growth hopes remain intact. Oracle shed 21,000 roles over the past year amid wave of AI layoffs from tech giants
Insider Buying and Selling
In other Oracle news, EVP Stuart Levey sold 15,000 shares of the business’s stock in a transaction on Thursday, April 16th. The stock was sold at an average price of $176.19, for a total value of $2,642,850.00. Following the transaction, the executive vice president owned 3,429 shares of the company’s stock, valued at approximately $604,155.51. The trade was a 81.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 40.90% of the company’s stock.
Oracle Company Profile
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
See Also
- Five stocks we like better than Oracle
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
